|
|
| Phases of Development | Preclinical | Phase I | Phase II | Registration | Approved | Marketed |
|---|
| Autoimmune | 1 | 0 | 1 | 0 | 0 | 0 | | Cancer | 4 | 4 | 5 | 0 | 2 | 3 | | Cardiovascular | 0 | 0 | 0 | 1 | 0 | 0 | | Hematology | 0 | 0 | 0 | 0 | 0 | 1 | | Musculoskeletal | 1 | 0 | 0 | 0 | 0 | 0 | | Neurology | 1 | 0 | 0 | 0 | 0 | 0 | | Renal | 0 | 0 | 1 | 0 | 0 | 0 |
|
|
Products Targeting BCR-ABL tyrosine kinase